AAAAAA
Results:
1-8
|
Results: 8
Authors:
Reliquet, V
Robillard, N
Perre, P
Muller, JY
Raffi, F
Audrain, M
Citation: V. Reliquet et al., Immune response to antiretroviral treatment combining stavudine, didanosine and nevirapine, PRESSE MED, 30(23), 2001, pp. 1143-1147
Authors:
Raffi, F
Reliquet, V
Ferre, V
Arvieux, C
Hascoet, C
Bellein, V
Besnier, JM
Breuz, JP
Garre, M
May, T
Molina, JM
Perre, P
Raguin, G
Rozenbaum, W
Zucman, D
Citation: F. Raffi et al., The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults, ANTIVIR TH, 5(4), 2000, pp. 267-272
Authors:
Raffi, F
Bonnet, B
Ferre, V
Esnault, JL
Perre, P
Reliquet, V
Leautez, S
Bouillant, C
Vergnoux, O
Weinbreck, P
Citation: F. Raffi et al., Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA, CLIN INF D, 31(5), 2000, pp. 1274-1278
Authors:
Reliquet, V
Ferre, V
Hascoet, C
Besnier, JM
Bellein, V
Arvieux, C
Molina, JM
Breux, JP
Zucman, D
Rozenbaum, W
Allavena, C
Raffi, F
Citation: V. Reliquet et al., Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients, ANTIVIR TH, 4, 1999, pp. 83-84
Authors:
Raffi, F
Franck, J
Pelloux, H
Derouin, F
Reliquet, V
Ambroise-Thomas, P
Aboulker, JP
Leport, C
Dumon, H
Citation: F. Raffi et al., Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis, DIAG MICR I, 34(1), 1999, pp. 51-56
Authors:
Gueglio, B
Billaud, E
Bani-Sadr, F
Allavena, C
Francois, C
Reliquet, V
Huart, A
Besnier, M
Leaute, S
Milpied, B
Raffi, F
Citation: B. Gueglio et al., HIV highly active antiretroviral therapy: 144 patients followed up in a reference center for AIDS in western France (Nantes Hospital)., MED MAL INF, 29(3), 1999, pp. 147-153
Authors:
Allavena, C
Francois, C
Reliquet, V
Perre, P
Michau, C
Peytavin, G
Raffi, F
Citation: C. Allavena et al., Experience of once daily nevirapine in 93 HIV-infected patients., PATH BIOL, 47(5), 1999, pp. 563-565
Authors:
Raffi, F
Reliquet, V
Francois, C
Garre, M
Hascoet, C
Allavena, C
Arvieux, C
Breux, JP
Perre, P
Rozenbaum, W
Auger, S
Citation: F. Raffi et al., Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results, ANTIVIR TH, 3, 1998, pp. 57-60
Risultati:
1-8
|